NDA Partners Expert Consultant Vinod Shah, PhD, receives AAPS Distinguished Pharmaceutical Scientist Award

I am deeply honored to receive this award for my contributions to the development of methodology and standards for dissolution/drug release of drug products to assure product quality and performance, and for my work to establish a scientific basis for the Biopharmaceutics Classification System.

NDA Partners Chairman Carl Peck, MD, announced today that one of the firm’s most prominent Expert Consultants, Dr. Vinod Shah, was recently honored as the recipient of the 2017 Distinguished Pharmaceutical Scientist award conferred by the American Association of Pharmaceutical Scientists (AAPS). The award was presented to Dr. Shah at the AAPS Annual meeting held in San Diego, California on November 12-15, 2017. The Distinguished Pharmaceutical Scientist award is intended to recognize the accomplishments of an individual that have been outstanding because of the impact of his or her work in the pharmaceutical sciences. The work must have significantly moved the frontier of the field and advanced basic concepts of important scientific significance which have stimulated research investigations by others. Dr. Shah was recognized for his contributions to the development of methodology and standards for dissolution/drug release of various types of drug products to assure product quality and performance.

Dr. Shah was formerly a Senior Research Scientist in the Office of Pharmaceutical Sciences at the US Food & Drug Administration (FDA). During his 30-year tenue at the FDA, he developed several regulatory guidelines with “How to Information” in the area of bioanalytical method validation, dissolution, bioavailability/bioequivalence, scale-up and post approval changes (SUPAC), and led efforts to establish the scientific basis for the Biopharmaceutics Classification System (BCS).

“I am deeply honored to receive this award for my contributions to the development of methodology and standards for dissolution/drug release of drug products and to assure product quality and performance and for my work to establish a scientific basis for the Biopharmaceutics Classification System. I hope my work will continue to make an impact in this field,” said Dr. Shah.

Dr. Shah joined NDA Partners as an Expert Consultant in 2016. In addition to his…

Read the full article from the Source…

Leave a Reply

Your email address will not be published. Required fields are marked *